Japan Would Offer Unapproved Ebola Drug

Monday, 25 Aug 2014 08:32 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
Japan would like to offer a drug to help treat the deadly Ebola virus before the World Health Organization officially rules on its use, the country's top government spokesman said on Monday.
 
Chief Cabinet Secretary Yoshihide Suga told a news conference that Japan has received inquiries from some countries on the influenza drug favipiravir, or T-705 as it is known in the developmental code.
 
"I am informed that medical professionals could make a request for T-705 in an emergency even before a decision (on approval) by the WHO. In that case, we would like to respond under certain criteria," he said.
 
Japan's Fujifilm Holdings Corp and U.S. partner MediVector are in talks with the U.S. Food and Drug Administration to submit an application to expand the use of favipiravir as a treatment for Ebola. [ID:nL4N0QH4ZR]
 
Following Suga's comments, Fujifilm shares rose 4.0 percent, edging near a four-year peak hit earlier this month. They were the eighth most actively traded shares on the Tokyo Stock Exchange's main board.
 
The Ebola epidemic in West Africa has killed more than 1,000 people and prompted the WHO to declare an international health emergency.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Health Officials Vow to Stop Ebola From Spreading in US

Tuesday, 30 Sep 2014 20:57 PM

A man who flew from Liberia to Texas has become the first patient infected with the deadly Ebola virus to be diagnosed i . . .

Spacing Between Sibling Births Linked to Autism Risk

Tuesday, 30 Sep 2014 19:13 PM

Children conceived either less than one year or more than five years after the birth of a sibling could be at increased  . . .

Light at Night May Hamper Breast Cancer Treatment: Study

Tuesday, 30 Sep 2014 19:08 PM

A study in rats hints that exposure to dim light at night may make human breast cancer tumors resistant to the chemother . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved